allopurinol has been researched along with Marfan-Syndrome* in 1 studies
1 other study(ies) available for allopurinol and Marfan-Syndrome
Article | Year |
---|---|
Allopurinol blocks aortic aneurysm in a mouse model of Marfan syndrome via reducing aortic oxidative stress.
Increasing evidence indicates that redox stress participates in MFS aortopathy, though its mechanistic contribution is little known. We reported elevated reactive oxygen species (ROS) formation and NADPH oxidase NOX4 upregulation in MFS patients and mouse aortae. Here we address the contribution of xanthine oxidoreductase (XOR), which catabolizes purines into uric acid and ROS in MFS aortopathy.. In aortic samples from MFS patients, XOR protein expression, revealed by immunohistochemistry, increased in both the tunicae intima and media of the dilated zone. In MFS mice (Fbn1. Allopurinol interferes in aortic aneurysm progression acting as a potent antioxidant. This study strengthens the concept that redox stress is an important determinant of aortic aneurysm formation and progression in MFS and warrants the evaluation of ALO therapy in MFS patients. Topics: Allopurinol; Animals; Aorta; Aortic Aneurysm; Disease Models, Animal; Hydrogen Peroxide; Marfan Syndrome; Mice; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2022 |